New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/mrd-guided-azacitidine-may-delay-relapse-aml-mds-2026a1000a15?src=rss
Author :
Publish date : 2026-04-02 09:43:00
Copyright for syndicated content belongs to the linked Source.
